Menopause is a natural stage of life. Still, it can bring real changes to how you sleep, feel, and move through your day. For many women, one question comes up again and again: what about hormone therapy?
For more than 20 years, menopause hormone therapy (often called hormone replacement therapy, or HRT) had a confusing reputation. Then, in 2026, the U.S. Food and Drug Administration (FDA) updated the safety labels on several hormone therapy products. That news sparked a lot of new questions.
This guide explains what happens to your hormones during menopause, what hormone therapy is, what changed with the FDA, and what current research shows. Our goal is simple: to help you understand the science so you can have a more informed conversation with your healthcare provider.
What Happens to Your Hormones During Menopause?
Menopause is officially reached after 12 months in a row without a menstrual period. In the U.S., it most often happens in a woman's early 50s. The years leading up to it are called perimenopause. This stage can last several years.
During perimenopause and menopause, the ovaries make less estrogen and progesterone. These hormone levels don't drop in a smooth line. They often rise and fall unevenly before settling at lower levels.
Estrogen does more than support reproduction. Your body has estrogen receptors (places where the hormone attaches and sends signals) in the brain, bones, skin, blood vessels, and urinary tract. That's one reason menopause can affect so many parts of the body.
Common menopause symptoms include:
-
Hot flashes and night sweats. Doctors call these vasomotor symptoms. They are sudden waves of heat, often with flushing and sweating. Up to 80% of women experience them, and they can last for years.
-
Sleep changes, which are often linked to night sweats.
-
Vaginal dryness and urinary changes. The medical term is genitourinary syndrome of menopause.
-
Mood shifts and changes in focus or memory.
-
Bone density changes, since estrogen plays a role in keeping bones strong.
Every woman's experience is different. Some notice very few changes. Others find their daily life is strongly affected.
What Is Menopause Hormone Therapy?
Menopause hormone therapy is a group of prescription medicines that contain estrogen. Many also contain a progestogen, which is progesterone or a similar hormone.
Hormone therapy comes in two main types:
-
Systemic therapy travels through the whole body. It comes as pills, skin patches, gels, or sprays.
-
Local (vaginal) therapy is a low-dose cream, ring, or tablet used in the vagina. Very little of it reaches the rest of the body.
Women who still have a uterus and use systemic estrogen are usually also prescribed a progestogen. This helps protect the lining of the uterus, because estrogen alone can raise the risk of endometrial (uterine lining) cancer.
Why Hormone Therapy Got a Bad Reputation
In 2002, early results from a large study called the Women's Health Initiative (WHI) reported higher rates of heart disease, stroke, blood clots, and breast cancer in some women taking hormone therapy. In response, the FDA added a "boxed warning" to hormone therapy labels. A boxed warning, sometimes called a black box warning, is the FDA's most prominent type of safety alert.
Many women stopped hormone therapy, and many doctors stopped prescribing it. Over the next two decades, researchers took a closer look at the WHI data. They paid special attention to when women started hormone therapy. Many WHI participants were older and many years past menopause when they began. Researchers found that age and timing appeared to make a meaningful difference in risk.
What the FDA Changed in 2026
On November 10, 2025, the FDA asked makers of menopause hormone therapy to update their labels. Then, on February 12, 2026, the FDA approved the first labeling changes for six products.
Here is what changed:
- The boxed warning language about cardiovascular disease, breast cancer, and probable dementia was removed from those products.
- The boxed warning about endometrial cancer stays on systemic estrogen-alone products for women who still have a uterus.
- Information about potential risks still appears elsewhere in the full prescribing information.
The FDA said its decision followed a broad review of the WHI and later research. That review focused closely on timing and on use during the earlier years after menopause. Dozens of manufacturers have submitted label updates, and more approvals are expected over time.
It's important to be clear about one thing: removing a boxed warning does not mean hormone therapy is risk-free. It means the FDA updated how the risks are explained.
What Current Research Shows
The Menopause Society (formerly the North American Menopause Society) publishes a position statement that summarizes the evidence on hormone therapy. Its most recent hormone therapy statement, published in 2022, reported several key findings:
- Hormone therapy is the most effective option studied for hot flashes, night sweats, and genitourinary syndrome of menopause.
- For women younger than 60 or within 10 years of menopause onset who have no reasons to avoid it, the potential benefits generally outweigh the risks for managing hot flashes and helping prevent bone loss.
- For women who start hormone therapy at age 60 or older, or more than 10 years after menopause, the balance may be less favorable. In this group, the absolute risks of heart disease, stroke, blood clots, and dementia are higher.
- Risks depend on the type, dose, form, length of use, timing, and whether a progestogen is included.
- Hormone therapy is not recommended for preventing memory decline.
The U.S. Preventive Services Task Force (USPSTF) has also concluded that hormone therapy should not be used to prevent long-term conditions, like heart disease, in women after menopause. In other words, hormone therapy is studied mainly for managing bothersome menopause symptoms.
Hormone therapy is also not a fit for everyone. People with a history of breast cancer, stroke, heart attack, blood clots, unexplained vaginal bleeding, or active liver disease are generally advised against it. Only a healthcare provider who knows your full health history can help you weigh these factors.
Nonhormonal Options and Everyday Wellness
Not everyone can or wants to use hormones. In recent years, the FDA has approved two nonhormonal prescription medicines for moderate to severe hot flashes: fezolinetant (Veozah) and elinzanetant (Lynkuet), approved in October 2025. These medicines work on receptors in the part of the brain that helps control body temperature. Like any medicine, they come with their own possible side effects, including effects on the liver, which a provider monitors.
Many health organizations also encourage general healthy habits during midlife for overall wellness. These include regular physical activity, a balanced eating pattern, consistent sleep routines, not smoking, and finding ways to manage everyday stress. Some women also notice that things like warm rooms, alcohol, or spicy foods seem to come before their hot flashes. Keeping a simple symptom journal can help you spot your own patterns.
If you take any vitamins, herbs, or other supplements, share the full list with your healthcare provider. Some products can interact with prescription medicines.
Questions to Bring to Your Healthcare Provider
If you're curious about hormone therapy, these questions can help start the conversation:
- Based on my age and how long it has been since menopause, how do the benefits and risks compare for me?
- Does my personal or family health history affect whether hormone therapy is an option?
- What's the difference between pills, patches, and vaginal options?
- Would I need a progestogen?
- What nonhormonal options are available?
- How often should we review my plan?
The Bottom Line
The science on menopause hormone therapy has changed a lot over the past 20 years. The FDA's 2026 label updates reflect a more detailed view of the research, especially about age and timing. Still, hormone therapy is a personal decision with real benefits and real risks. The best choice depends on your health history, your symptoms, and your goals.
Understanding how your body changes during menopause is a powerful first step. From there, an open, honest talk with a trusted healthcare provider can help you decide what's right for you.
References
- U.S. Food and Drug Administration. "FDA Approves Labeling Changes to Menopausal Hormone Therapy Products." News release, February 12, 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-labeling-changes-menopausal-hormone-therapy-products
- "Updated Labeling for Menopausal Hormone Therapy." JAMA Viewpoint. https://jamanetwork.com/journals/jama/fullarticle/2841321
- The North American Menopause Society (now The Menopause Society). "The 2022 Hormone Therapy Position Statement of The North American Menopause Society." Menopause. 2022;29(7):767–794.
- U.S. Preventive Services Task Force. "Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement." JAMA. 2022;328(17):1740–1746.
- McNulty R. "FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause." AJMC, October 24, 2025. https://www.ajmc.com/view/fda-approves-elinzanetant-a-hormone-free-option-for-hot-flashes-in-menopause
Disclaimer
Educational content only. This article is not medical advice. Talk with a healthcare provider before you change your diet or start a supplement. *These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.